Submit Article
Back to Journal

SM Vaccines and Vaccination Journal

Schistosome Immunomics: High-Throughput Vaccine and Diagnostic Antigen Discovery

Abstract
Details

Received: 02-Sep-2015

Accepted: 04-Sep-2015

Published: 15-Sep-2015

Letter to the Editor | Volume 1 - Issue 2 | Article DOI :

Download PDF

Yang Guo, Bei Li, Xuzhi Ruan, Zongyun Chen and Jian Li*

Institute of Basic Medical Sciences, College of Basic Medicine, Hubei University of Medicine, People’s Republic of China

Corresponding Author:

Jian Li, Institute of Basic Medical

Sciences, Hubei University of Medicine,

People’s Republic of China, Tel: +86-

719-8875305;

Abstract

Schistosomiasis remains one of the highly prevalent and serious helminthiases in the countries of Asia, Africa and Latin America. Despite the accessibility of an effective drug against the fatal parasites, drug-based treatment projects still have certain limitations and it is likely that vaccine and effective diagnostic tools are essential for schistosomiasis control. Despite the several decade vaccine development has witnessed the finding and testing of couple of candidate targets, none have shown satisfactory protection. Upon the coming of genome era, it has revolutionized the study of the drug, vaccine, and immunodiagnosis, and also catalyzed a switch from traditional manual testing to automation operation.

Citation

Guo Y, Li B, Ruan X, Chen Z and Li J. Schistosome Immunomics: High-Throughput Vaccine and Diagnostic Antigen Discovery. SM Vaccine Vaccin. 2015;1(2):1006.